UK MHRA · August 05, 2026

Guidance: Innovative Licensing and Access Pathway (ILAP)

ILAP is a pathway to accelerate regulatory approval and NHS access for transformative new medicines.

High impact Pharmaceuticals Market Access & Reimbursement UK Pharmaceuticals

The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.